A list of facilities included in Allergan’s GHG inventory can be found in Appendix A. Assurance Conclusion Based on the approach described above, and the GHG reporting criteria applied, it is ERM CVS’s opinion that the reported Scope and Scope 2 GHG data set out in Section CC8.2 & CC8.3 of Allergan’s CDP response for its global operationally controlled facilities (excluding those facilities in its generic medicines portfolio) are free from material misstatement.